Frazier Life Sciences Acquisition Corp. II (FLSC)
NASDAQ
Closed
Oct 20, 2026
Day's Range
10.2652 wk Range
10.18Overview - FLSC - Frazier Life Sciences Acquisition Corp. II
Key Statistics
Profitability
Profit Margin
‪0.00%‬
Operating Margin
‪0.00%‬
Ownership
Shares Outstanding
9.67M
Price stats
50-Day Avg
‪10.29‬
200-Day Avg
‪10.29‬
Market Cap - FLSC - Frazier Life Sciences Acquisition Corp. II
Peers - FLSC - Frazier Life Sciences Acquisition Corp. II
Peer Comparison
Compared with companies in Shell Companies listed on NASDAQ.
- FLFLSCNASDAQFrazier Life Sciences Acquisition Corp. II100.13MMarket Cap+0.58%52-week change—P/E (Trailing)‪0.00%‬Profit Margin
- SLVRNASDAQSprott Silver Miners & Physical Silver ETF1.27BMarket Cap+16.41%52-week change22.49P/E (Trailing)—Profit Margin
- AVRNASDAQAnteris Technologies Global Corp.659.79MMarket Cap+34.27%52-week change-2.66P/E (Trailing)‪70.25%‬Profit Margin
- DMDMIINASDAQDrugs Made In America Acquisition II Corp.648.46MMarket Cap+2.95%52-week change33.93P/E (Trailing)‪0.00%‬Profit Margin
- CECEPFNASDAQCantor Equity Partners IV, Inc. Class A Ordinary Shares586.35MMarket Cap-2.44%52-week change31.09P/E (Trailing)‪0.00%‬Profit Margin
- CCXINASDAQChemoCentryx Inc583.73MMarket Cap+2.10%52-week change-5.54P/E (Trailing)‪99.05%‬Profit Margin
- MLMLAANASDAQMountain Lake Acquisition Corp. II490.28MMarket Cap+1.50%52-week change—P/E (Trailing)‪0.00%‬Profit Margin
Profile Summary - FLSC - Frazier Life Sciences Acquisition Corp. II
About
Frazier Life Sciences Acquisition Corp. II is a special purpose acquisition company focused on identifying a business in the biotechnology and life sciences sectors for a potential business combination. Its search may encompass companies developing innovative therapies, genetic medicines, molecular cancer treatments,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
